Trials / Unknown
UnknownNCT05198128
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
Ovarian Hyper Stimulation Syndrome Using Calcium Infusion
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART
Detailed description
Among assisted reproductive technologies (ART), ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication affects up to 30% of women undergoing ART and caries high risks of morbidity and mortality. Women with age younger than 35 years, those with history of polycystic ovary syndrome (PCOS), or having a history of previous OHSS are more susceptible to develop OHSS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium intravenous infsuion | intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group. Intravenous infusion was performed within 30 minutes |
| DRUG | 0.9 % saline | 0.9 % saline |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-04-25
- Completion
- 2023-05-10
- First posted
- 2022-01-20
- Last updated
- 2022-02-22
Source: ClinicalTrials.gov record NCT05198128. Inclusion in this directory is not an endorsement.